26659605|t|Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy.
26659605|a|Peroxisomal proliferator-activated receptor gamma (PPARgamma) is a nuclear hormone receptor whose agonist, rosiglitazone has a neuroprotective effect to hippocampal neurons in pilocarpine-induced seizures. Hippocampal slice preparations treated in Mg2+ free medium can induce ictal and interictal-like epileptiform discharges, which is regarded as an in vitro model of N-methyl-D-aspartate (NMDA) receptor-mediated temporal lobe epilepsy (TLE). We applied rosiglitazone in hippocampal slices treated in Mg2+ free medium. The effects of rosiglitazone on hippocampal CA1-Schaffer collateral synaptic transmission were tested. We also examined the neuroprotective effect of rosiglitazone toward NMDA excitotoxicity on cultured hippocampal slices. Application of 10 muM rosiglitazone significantly suppressed amplitude and frequency of epileptiform discharges in CA1 neurons. Pretreatment with the PPARgamma antagonist GW9662 did not block the effect of rosiglitazone on suppressing discharge frequency, but reverse the effect on suppressing discharge amplitude. Application of rosiglitazone suppressed synaptic transmission in the CA1-Schaffer collateral pathway. By miniature excitatory-potential synaptic current (mEPSC) analysis, rosiglitazone significantly suppressed presynaptic neurotransmitter release. This phenomenon can be reversed by pretreating PPARgamma antagonist GW9662. Also, rosiglitazone protected cultured hippocampal slices from NMDA-induced excitotoxicity. The protective effect of 10 muM rosiglitazone was partially antagonized by concomitant high dose GW9662 treatment, indicating that this effect is partially mediated by PPARgamma receptors. In conclusion, rosiglitazone suppressed NMDA receptor-mediated epileptiform discharges by inhibition of presynaptic neurotransmitter release. Rosiglitazone protected hippocampal slice from NMDA excitotoxicity partially by PPARgamma activation. We suggest that rosiglitazone could be a potential agent to treat patients with TLE.
26659605	0	13	Rosiglitazone	Chemical	MESH:D000077154
26659605	34	42	Seizures	Disease	MESH:D012640
26659605	46	57	Hippocampal	CellLine	
26659605	90	99	Glutamate	Chemical	MESH:D018698
26659605	122	144	Temporal Lobe Epilepsy	Disease	MESH:D004833
26659605	146	195	Peroxisomal proliferator-activated receptor gamma	Gene	5468
26659605	197	206	PPARgamma	Gene	5468
26659605	253	266	rosiglitazone	Chemical	MESH:D000077154
26659605	299	310	hippocampal	CellLine	
26659605	322	333	pilocarpine	Chemical	MESH:D010862
26659605	342	350	seizures	Disease	MESH:D012640
26659605	352	363	Hippocampal	CellLine	
26659605	394	398	Mg2+	Chemical	-
26659605	448	471	epileptiform discharges	Disease	MESH:D019522
26659605	561	583	temporal lobe epilepsy	Disease	MESH:D004833
26659605	585	588	TLE	Disease	MESH:D004833
26659605	602	615	rosiglitazone	Chemical	MESH:D000077154
26659605	619	630	hippocampal	CellLine	
26659605	649	653	Mg2+	Chemical	-
26659605	682	695	rosiglitazone	Chemical	MESH:D000077154
26659605	699	710	hippocampal	CellLine	
26659605	817	830	rosiglitazone	Chemical	MESH:D000077154
26659605	843	857	excitotoxicity	Disease	
26659605	870	881	hippocampal	CellLine	
26659605	912	925	rosiglitazone	Chemical	MESH:D000077154
26659605	978	1001	epileptiform discharges	Disease	MESH:D019522
26659605	1040	1049	PPARgamma	Gene	5468
26659605	1061	1067	GW9662	Chemical	MESH:C457499
26659605	1096	1109	rosiglitazone	Chemical	MESH:D000077154
26659605	1220	1233	rosiglitazone	Chemical	MESH:D000077154
26659605	1376	1389	rosiglitazone	Chemical	MESH:D000077154
26659605	1500	1509	PPARgamma	Gene	5468
26659605	1521	1527	GW9662	Chemical	MESH:C457499
26659605	1535	1548	rosiglitazone	Chemical	MESH:D000077154
26659605	1568	1579	hippocampal	CellLine	
26659605	1605	1619	excitotoxicity	Disease	
26659605	1653	1666	rosiglitazone	Chemical	MESH:D000077154
26659605	1718	1724	GW9662	Chemical	MESH:C457499
26659605	1825	1838	rosiglitazone	Chemical	MESH:D000077154
26659605	1873	1896	epileptiform discharges	Disease	MESH:D019522
26659605	1952	1965	Rosiglitazone	Chemical	MESH:D000077154
26659605	1976	1987	hippocampal	CellLine	
26659605	2004	2018	excitotoxicity	Disease	
26659605	2032	2041	PPARgamma	Gene	5468
26659605	2070	2083	rosiglitazone	Chemical	MESH:D000077154
26659605	2120	2128	patients	Species	9606
26659605	2134	2137	TLE	Disease	MESH:D004833
26659605	Association	MESH:D018698	MESH:D004833
26659605	Negative_Correlation	MESH:C457499	5468
26659605	Negative_Correlation	MESH:D000077154	MESH:D019522
26659605	Positive_Correlation	MESH:D000077154	5468
26659605	Negative_Correlation	MESH:D000077154	MESH:D018698
26659605	Association	MESH:D018698	MESH:D012640
26659605	Negative_Correlation	MESH:D000077154	MESH:D012640
26659605	Negative_Correlation	MESH:D000077154	MESH:D004833
26659605	Positive_Correlation	MESH:D010862	MESH:D012640

